Progress of Research on Cervical Cancer-related Bio-markers

Yanxia Hu,Guonan Zhang
DOI: https://doi.org/10. 3969/j. issn. 1674-0904. 2019. 02. 008
2019-01-01
Abstract:Cervical cancer is one of the leading causes of death in developing countries. High risk human papillomavirus infection is considered to be one of the pathogenic factors. Although the screening and diagnosis methods of cervical cancer are increasingly perfect, traditional surgery, chemotherapy, and radiotherapy have not achieved satisfactory therapeutic effects, and the prognosis of patients in advanced stage is poor. Bio-markers commonly found in blood, tissue or other body fluids as a marker of normal or abnormal pathological state can be detected via genetics, proteomics, cellular or molecular methods. Currently, some cervical cancer-related markers have been widely recognized and used clinically. In recent years, studies have found that some long-chain non-coding RNAs and microRNAs have certain value in screening, diagnosis, prog-nosis, treatment response assessment, and detection of cancer recurrence. A review of relevant research progress is now a-vailable.
What problem does this paper attempt to address?